Advanced search×

Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes.

Khalid Al KA Ghofaili, Michelle M Fung, Ziliang Z Ao, Mark M Meloche, R Jean RJ Shapiro, Garth L GL Warnock, Dariush D Elahi, Graydon S GS Meneilly, and David M DM Thompson

Transplantation 83(1):24-8 (2007) PMID 17220786

Islet transplantation can reduce or eliminate the need for insulin in patients with type 1 diabetes. Exenatide is a long acting analogue of Glucagon-like peptide-1 (GLP-1) that augments glucose induced insulin secretion, and may increase beta cell mass. We evaluated the effect of exenatide on insulin secretion after islet transplantation.

DOI: 10.1097/01.tp.0000251379.46596.2d
Version: za2963e q8za0 q8zbc q8zc7 q8zde q8ze3 q8zf7 q8zg9
Buy PDF

Similar articles you may find interesting…

  1. The incretin mimetic exenatide as a monotherapy in patients with type 2 diabetes.
    Patric P Nelson, Terri T Poon, ... Mark M Fineman

    Diabetes Technol Ther 9(4):317-26 (2007) PMID 17705687

    Exenatide twice-daily monotherapy resulted in glycemic improvements and reductions in body weight comparable to that of exenatide combination therapy with metformin in patients with type 2 diabetes....
    Buy PDF
  2. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency ...
    Catherine A CA Sheffield, Michael P MP Kane, and Robert S RS Busch

    Pharmacotherapy 27(10):1449-55 (2007) PMID 17896900

    We report the successful off-label use of exenatide in an obese, 40-year-old man with type 1 diabetes and human immunodeficiency virus (HIV) infection who had gastrointestinal intolerance to pramlintide. The patient had experienced a dramatic weight gain secondary to his antiretroviral drugs. This w...
    Buy PDF
  3. Does adding exenatide to insulin treatment benefit patients with type 2 diabetes?
    Author(s) unavailable

    Ann Intern Med 154(2):I40 (2011) PMID 21135289

    Buy PDF